Digestive Diseases and Sciences

, Volume 50, Supplement 1, pp S119–S123

Rebamipide Enemas–New Effective Treatment for Patients with Corticosteroid Dependent or Resistant Ulcerative Colitis

Authors

    • Department of GastroenterologyAichi Medical University School of Medicine
  • Kunio Kasugai
    • Department of GastroenterologyAichi Medical University School of Medicine
  • Tetsuya Ishikawa
    • Department of GastroenterologyAichi Medical University School of Medicine
  • Shinichi Kakumu
    • Department of GastroenterologyAichi Medical University School of Medicine
  • Masafumi Onishi
    • Department of GastroenterologyAichi Medical University School of Medicine
  • Takeshi Mori
    • Department of GastroenterologyAichi Medical University School of Medicine
Article

DOI: 10.1007/s10620-005-2816-1

Cite this article as:
Miyata, M., Kasugai, K., Ishikawa, T. et al. Dig Dis Sci (2005) 50: S119. doi:10.1007/s10620-005-2816-1

Abstract

In this study we investigated the effect of rebamipide enema in patients with steroid-resistant and/or dependent ulcerative colitis. Rebamipide enemas were administered twice daily for a 12-week period; this treatment was further continued longer in patients who requested this. Disease activity index as reflecting the clinical condition and endoscopic index with histological grading were determined before and after the treatment period. Nine of 11 (81.8%) patients on 12-week treatment with rebamipide approved and were classified as colitis in remission. Moreover, seven of 11 patients requested long-term medication, the longest medication term being 80 weeks. These results medicated that rebamipide enemas may be effective in patients with steroid-resistant and/or dependent ulcerative colitis.

Key Words

ulcerative colitisrebamipide enemasteroid-resistancesteroid-dependencylong-term administration

Copyright information

© Springer Science + Business Media, Inc. 2005